Skip to content
  • Rheuma Pics Hub
  • Rheuma Calculator
  • Books
  • Account
  • Dashboard
  • Login
  • Logout
  • Register
  • Rheuma Tv in 2024
Rheuma Tv
  • Home
  • Student Corner
    • PG Section
    • UG Section
  • Case Discussion
  • Research
    • Journal Club
  • Webinar
    • Live Webinar
      • Biologics in AIRD
      • AIRD and INFLAMMATION
      • SLE and Inflammation
      • Immunology and Inflammation
      • Eye and Rheumatology Series
      • Investigation in Rheumatology
      • Expert Talk
      • Tofacitinib in Rheumatology
      • CS DMARDS in RA
    • Past Webinar
    • Webinar Registration
  • News and Views
  • Conference
    • ChanRe Update 2024
    • ChanRe Update 2023
    • ChanRe Update 2022
    • ChanRe Update 2021
    • SIRCON 2023
    • Karnataka Vasculitis Club
  • Quiz
  • Courses

Rheuma Tv

Strong genetic predisposition with direct functional implications reported in autoimmune 2 neurological syndromes

April 5, 2022

The findings of a genome-wide association study (GWAS) published in Brain reported the association of genes in supplying neural structure and immune function in anti-glutamic …

Read more

Janus kinase inhibitors do not impair pneumococcal conjugate vaccine immunogenicity in RA

April 1, 2022

Pneumococcal vaccination such as PCV13 and PPV23 is recommended in RA patients due to the substantial risk of pneumococcal infections. However, previous studies have reported …

Read more

Baricitinib and tofacitinib are as effective as bDMARDs in RA

March 31, 2022

Current treatment guidelines for RA hail janus kinase inhibitors (JAKis) alongside biologics as effective therapeutic options for patients refractory to initial conventional synthetic DMARDs. A …

Read more

Eye and Rheumatology Series- 5 Uveitis Part 2

July 16, 2024March 29, 2022

  Dr. Sanjay S spoke about intermediate uveitis. Inflammation in the vitreous humor, ciliary body, or peripheral retina is known as intermediate uveitis. Treatment of …

Read more

The potential role of vitamin K-dependent protein S (PROS) in predicting response to the methotrexate/etanercept combination in RA

March 29, 2022March 29, 2022

Vitamin K-dependent protein S (PROS) can function as a prospective biomarker in predicting response to the methotrexate (MTX)/etanercept (ETA) combination in patients with rheumatoid arthritis …

Read more

Hematological indices useful in monitoring disease activity in patients with RA treated with JAK inhibitors

March 28, 2022

Literature studies validate the role of hematological indices as reliable markers for the assessment of disease activity in rheumatoid arthritis (RA). A recent study published …

Read more

Concomitant administration of tacrolimus and biological DMARDS, a potential rescue therapy in rheumatoid arthritis

March 26, 2022March 26, 2022

Tacrolimus administered along with biological disease-modifying anti-rheumatic drugs (bDMARDs) showed elevated retention rates compared to bDMARDs therapy without tacrolimus (TAC) or methotrexate (MTX), according to …

Read more

Can Iberodomide be a novel drug in SLE management?

March 25, 2022
Can Iberodomide be a novel drug in SLE management?

The findings of a 24-week, phase 2 trial published in the recent issue of the New England Journal of Medicine have demonstrated that iberdomide at …

Read more

Case of 34-year-old female – polyarthritis and erythematous skin rash – 29/03/2022

May 20, 2022March 22, 2022

[ays_quiz id=’11’]   A 34-year-old married female presented with joint pains that started with bilateral ankle pain with swelling and developed into a pain in …

Read more

Older posts
Newer posts
← Previous Page1 … Page25 Page26 Page27 … Page39 Next →

Important Links

  • Privacy Policy
  • Contact Us
  • Disclaimer
  • About Us
  • Terms and Conditions
  • Cancellation Policy
  • Refund Policy
  • Partner With Us

Disclaimer

This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. @2020 ChanRe Healthcare & Research Pvt Ltd.

Copyright © 2025 DMCA.com Protection Status
  • Home
  • Student Corner
    • PG Section
    • UG Section
  • Case Discussion
  • Research
    • Journal Club
  • Webinar
    • Live Webinar
      • Biologics in AIRD
      • AIRD and INFLAMMATION
      • SLE and Inflammation
      • Immunology and Inflammation
      • Eye and Rheumatology Series
      • Investigation in Rheumatology
      • Expert Talk
      • Tofacitinib in Rheumatology
      • CS DMARDS in RA
    • Past Webinar
    • Webinar Registration
  • News and Views
  • Conference
    • ChanRe Update 2024
    • ChanRe Update 2023
    • ChanRe Update 2022
    • ChanRe Update 2021
    • SIRCON 2023
    • Karnataka Vasculitis Club
  • Quiz
  • Courses